Nijmegen, the Netherlands –  Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting has achieved CE marking under the In Vitro Diagnostic...

Nijmegen, The Netherlands – LUMO Labs’ pre-seed investment vehicle LUMO Fund II TTT AI announces an investment in Aiosyn B.V. Aiosyn’s clinical diagnostics platform uses AI-powered pathology algorithms to support pathologists with more...

Delivering faster, more accurate and efficient tissue dissection Eindhoven, THE NETHERLANDS (July 20, 2021) – Xyall BV, a leading medtech innovator in molecular pathology, launches its Tissector High Throughput (HT) system for greater...

Exploring New Methods & Imaging Technologies for Cancer Immunotherapy Research Pathology Imaging User Group Meeting October 22-23, 2014 Erasmus University Medical Centre Bldg Ae, Rm 406 Rotterdam, The Netherlands   Reserve...